Training. The University of Liverpool has set up a Doctoral Training Network in Technologies for Healthy Ageing to train the next generation of physical scientists and engineers to develop novel technologies and devices to address the challenges faced by older people and our clinical colleagues who work with them. Read more
This industrial Collaborative Award in Science and Engineering (iCASE) studentship is offered by Warwick’s MRC Funded Doctoral Training Partnership (DTP). Read more
Outcome measures in clinical trials are invariably collected as infrequent snapshots of retrospective, self-reported symptoms during brief face-to-face clinic visits. Read more
The world leading specialist Sheffield MND Care and Research Centre at the Sheffield Institute of Translational Neuroscience (SITraN), University of Sheffield is leading the drive to develop and implement new technologies to improve the care for patients with motor neuron disease (MND). Read more
Global population projections indicate that older people (aged 65 years or older) are the fastest growing sector of the population, with the proportion… Read more
Magnetic field hyperthermia (MFH) is currently undergoing clinical trials for use in humans. The research to date has shown the effectiveness of the approach in cells and animal models and the initial results from human trials are promising. Read more
Huntington’s disease (HD) is a fatal, devastating neurological disorder characterised by complex motor, cognitive and neuropsychiatric symptoms. Read more
Background. Clinical decision-making requires clinicians to help patients weigh up the advantages and disadvantages of different diagnostic and treatment alternatives. Read more
We undertake translational cardiovascular research by moving from bench to bedside and vice versa; our main focus is the cross-talk between adipose tissue (AT) and the cardiovascular system. Read more
This industrial Collaborative Award in Science and Engineering (iCASE) studentship is offered by Warwick’s MRC Funded Doctoral Training Partnership (DTP). Read more
Programmed death-ligand 1(PD-L1), a negative regulator of the immune system, is highly expressed in newly-diagnosed and relapsed multiple myeloma patients, and its expression is associated with suppressed anti-tumour immunity. Read more
Proteomic approaches using mass spectrometric analysis have proved a valuable tool in understanding the molecular pathogenesis of complex disorders such as schizophrenia and ASD. Read more
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Monthly chance to win one of ten £10 Amazon vouchers; winners will be notified every month.*
Access to our £6,000 scholarship competition
Get funding opportunities & application tips
Weekly advice, student stories and study fairs
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Create your myFindAPhD account to add this PhD to your shortlist to register for this event
Due to your Facebook privacy settings, we were unable to create your account at this time. Please select another method to sign up.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
Continue with Facebook
Looking to list your PhD opportunities? Log in here.